UPDATE: MLV Initiates Coverage On Agios Pharmaceuticals By: Benzinga via Benzinga December 04, 2014 at 10:22 AM EST MLV initiated coverage on Agios Pharmaceuticals Inc (NASDAQ: AGIO) with a Buy rating and $123 price target. Analyst Arlinda Lee ... Read More >> Related Stocks: Agios Pharmaceuticals